Lisdexamphetamine: Phase III data

In an open-label Phase III trial in 269 pediatric patients, 6 months of

Read the full 132 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE